Dr. Anil Mandhani

Chairman Kidney and Urology Institute

About

More than two decades of experience in Urology

Former Professor, Urology at Sanjay Gandhi Post Graduate Institute of Medical Sciences

Clinical Fellow in robotic uro-oncology at Cornell Presbyterian Hospital, New York

Dr. Anil Mandhani is the Chairman of Kidney and Urology Institute at Medanta – The Medicity. He is a renowned urologist who has conducted a variety of complex oncological and reconstructive surge..

Medical Qualifications

QUALIFICATIONSINSTITUTE / DEPARTMENTYEAR
Clinical Fellowship in Robotic Uro-oncologyCornell/ New York Presbyterian Hospital, New York2007
Diplomat of National Board (DNB) in UrologyNational Board Examination, India1998
Magister of Chirugia (M.Ch.) in UrologySanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow1998
Master of Surgery (MS) in General SurgeryPt JNM Medical College, Ravishankar University, Raipur1993
Bachelor of Medicine and Bachelor of Surgery (MBBS)Pt JNM Medical College, Ravishankar University, Raipur1990

Specialization and Expertise

  • Uro - Oncology
  • Renal Transplantation
  • Robotic Surgery
  • Endo-Urological Surgery

Memberships & Certifications

  • Corresponding member of AUA
  • Member of European Urology
  • Fellow of American College of Surgeons
  • Member of BAUS
  • Member of Urological Society of India

Awards & Accomplishments

  • DUSUCON North zone urological society of India for best research work award, 2014
  • DUSUCON award on best clinical work on PSA characteristic in prostate cancer, 2013

Publications

  • ICMR :   To study the impact of chronic asymptomatic prostatitis on serum PSA level measuring seminal fluid interleukin-8 levels and its gene polymorphism,
  • UPCST :   Expression of androgen receptors at various stages of metastatic prostatic cancer and correlation with response pattern to ADT,
  • Cancer research grant from Pfizer :   Correlation of natural killer cell counts in whole blood and human leukocyte and antigen-g expression in tumor tissue of renal cell carcinoma patients.,
  • Cancer research grant from Pfizer :   Finding targets of micro RNA by western blot techniques in bladder cancer,
  • Cancer research grant from Pfizer :   Assessment of micro RNA expression and validation of its utility as a new marker of prognosticating the outcome of bladder cancer,
  • Cancer research grant from Pfizer :   Prediction of stone fragility by dual energy x-ray absorptiometry,
  • Cancer research grant from Pfizer :   Renal cell carcinoma in India present at an early age and in advanced stage,
  • Toxicol Int :   Tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in North Indian population., 2012
  • Indian J Urol. :   Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?, 2012
  • Indian J Urol. :   Does en-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen?, 2012

Media